| Assessing the impact of COVID-19 on liver cancer management (CERO-19) S Muñoz-Martínez, V Sapena, A Forner, JC Nault, G Sapisochin, ... JHEP reports 3 (3), 100260, 2021 | 56 | 2021 |
| Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF/TKI and immunotherapy NH Tran, S Muñoz, S Thompson, CL Hallemeier, J Bruix Hepatology 76 (4), 1203-1218, 2022 | 53 | 2022 |
| Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules M Sanduzzi-Zamparelli, Z Mariño, S Lens, V Sapena, G Iserte, A Pla, ... Journal of hepatology 76 (4), 874-882, 2022 | 31 | 2022 |
| Atypical manifestations of hepatitis A virus infection SG Muñoz-Martínez, HA Díaz-Hernández, D Suárez-Flores, ... Revista de Gastroenterología de México (English Edition) 83 (2), 134-143, 2018 | 31 | 2018 |
| Rethinking about flor yeast diversity and its dynamic in the “criaderas and soleras” biological aging system M Ruiz-Muñoz, G Cordero-Bueso, F Benítez-Trujillo, S Martínez, F Pérez, ... Food Microbiology 92, 103553, 2020 | 27 | 2020 |
| Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis I El Hajra, M Sanduzzi-Zamparelli, V Sapena, S Muñoz-Martínez, E Mauro, ... Hepatology 77 (4), 1139-1149, 2023 | 22 | 2023 |
| Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL F Koenig, C Spiertz, D Millar, S Rodríguez-Navarro, N Machín, ... EClinicalMedicine 67, 2024 | 19 | 2024 |
| Current pharmacological treatment of hepatocellular carcinoma S Muñoz-Martínez, G Iserte, M Sanduzzi-Zamparelli, N Llarch, M Reig Current Opinion in Pharmacology 60, 141-148, 2021 | 19 | 2021 |
| Outcome of liver cancer patients with SARS‐CoV‐2 infection: an international, multicentre, cohort study S Muñoz‐Martínez, V Sapena, A Forner, J Bruix, M Sanduzzi‐Zamparelli, ... Liver international 42 (8), 1891-1901, 2022 | 14 | 2022 |
| Phenotypes of metabolic dysfunction–associated steatotic liver disease–associated hepatocellular carcinoma J Rivera-Esteban, S Muñoz-Martínez, M Higuera, E Sena, ... Clinical Gastroenterology and Hepatology, 2024 | 12 | 2024 |
| Estudio piloto del beneficio de la utilización de un video como herramienta educativa en pacientes con diabetes tipo 2 SGM Martínez, IL Garber, D Cuevas, CA Salinas, ML Velasco, ... Revista de Endocrinología y Nutrición 20 (2), 56-62, 2012 | 10 | 2012 |
| Portopulmonary hypertension: an updated review EA Jasso-Baltazar, GA Peña-Arellano, J Aguirre-Valadez, I Ruiz, ... Transplantation Direct 9 (8), e1517, 2023 | 8 | 2023 |
| Early nivolumab addition to regorafenib in patients with hepatocellular carcinoma progressing under first-line therapy (GOING trial), interim analysis and safety profile. M Sanduzzi Zamparelli, A Matilla, JL Lledó, SM Martínez, M Varela, ... Journal of Clinical Oncology 40 (4_suppl), 428-428, 2022 | 7 | 2022 |
| Prevalence and Risk Factors of MASLD and liver fibrosis amongst the penitentiary population in catalonia: the prisonafld study J Rivera-Esteban, A Jiménez-Masip, S Muñoz-Martínez, S Augustin, ... Journal of Clinical Medicine 12 (23), 7276, 2023 | 6 | 2023 |
| Activated lymphocytes and increased risk of dermatologic adverse events during sorafenib therapy for hepatocellular carcinoma J Corominas, V Sapena, M Sanduzzi-Zamparelli, C Millán, E Samper, ... Cancers 13 (3), 426, 2021 | 5 | 2021 |
| Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Rep. 2021; 3 (3): 100260 S Muñoz-Martínez, V Sapena, A Forner, JC Nault, G Sapisochin, ... | 5 | 2021 |
| Estudio epidemiológico de la enfermedad por hígado graso en población mexicana SG Munoz Martínez, A Flores, A González Torre Sesión de carteles presentada en Semana Nacional de Gastroenterología, 2017 | 5 | 2017 |
| Platelet aggregation in whole blood, a new approach for understanding the antiplatelet effect of N-(3-hydroxy-1, 3, 5 (10)-estratrien-17b-yl) butylamine (buame) A De la Peña, M Flores, B Valente-Acosta, L Quintanar-Trejo, ... Proc West Pharmacol Soc 52, 50-53, 2009 | 5 | 2009 |
| Cholangiocarcinoma: early detection and screening in high-risk population S Muñoz-Martínez, J Rimola, MC Londoño, A Cárdenas, A Forner Hepatoma Research 8, N/A-N/A, 2022 | 4 | 2022 |
| Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction S Muñoz-Martínez, V Sapena, Á García-Criado, A Darnell, A Forner, ... Cancers 15 (13), 3269, 2023 | 3 | 2023 |
